Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay Vora

Showing results (51-60 of 166) with videos related to

Pageof 17
Sort By:
British Journal of Haematology|April 9, 2014
Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003Katharine Patrick, Rachel Wade, Nick Goulden, et al.
Leukemia|September 18, 2021
DNA-TG and risk of sinusoidal obstruction syndrome in childhood acute lymphoblastic leukemiaLinea Natalie Toksvang, Kathrine Grell, Stine Nygaard Nielsen, et al.
British Journal of Haematology|February 23, 2018
Early morphological response is significantly associated with, but does not accurately predict, relapse in teenagers and young adults aged 10-24 years with acute lymphoblastic leukaemia (ALL): results from UKALL2003Caroline L Furness, Amy Kirkwood, Clare Rowntree, et al.
British Journal of Haematology|July 2, 2021
Infant T-cell acute lymphoblastic leukaemia with t(6;7) (TCRB-MYB) translocationPemantah Sandheeah Ramdeny, Khushnuma Mullanfroze, Paola de Lorenzo, et al.
Journal of Pediatric Hematology/Oncology|March 29, 2020
Clinical Utility of Radiologic Disease Reassessment in the Management of Pediatric B-Cell Non-Hodgkin LymphomaKatherine Green, Vesna Pavasovic, Sara Ghorashian, et al.
Blood Advances|October 12, 2023
Cranial radiotherapy has minimal benefit in children with central nervous system involvement in T-ALLDavid O'Connor, Melvin Joy, Amir Enshaei, et al.
British Journal of Haematology|November 29, 2011
Improved outcome of allogeneic haemopoietic stem cell transplantation for children with Philadelphia positive acute lymphoblastic leukaemiaAnshu Garg, Adhithya Sankar, Janet Williams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2025
High-Dose Methotrexate in Children and Young Adults With ALL and Lymphoblastic Lymphoma: Results of the Randomized Phase III Study UKALL 2011Amy A Kirkwood, Nicholas Goulden, John Moppett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2013
Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal amplification of chromosome 21: a comparison of the MRC ALL97/99 and UKALL2003 trialsAnthony V Moorman, Hazel Robinson, Claire Schwab, et al.
Pediatric Blood & Cancer|December 24, 2022
National advisory panels for childhood cancer in the United Kingdom: An evaluation of current practice and a best practice statement for the futureSarah Brown, Tanzina Chowdhury, Matthew Collin, et al.
Pageof 17

Showing results (51-60 of 166) with videos related to

Sort By:
Pageof 17
British Journal of Haematology|April 9, 2014
Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003Katharine Patrick, Rachel Wade, Nick Goulden, et al.
Leukemia|September 18, 2021
DNA-TG and risk of sinusoidal obstruction syndrome in childhood acute lymphoblastic leukemiaLinea Natalie Toksvang, Kathrine Grell, Stine Nygaard Nielsen, et al.
British Journal of Haematology|February 23, 2018
Early morphological response is significantly associated with, but does not accurately predict, relapse in teenagers and young adults aged 10-24 years with acute lymphoblastic leukaemia (ALL): results from UKALL2003Caroline L Furness, Amy Kirkwood, Clare Rowntree, et al.
British Journal of Haematology|July 2, 2021
Infant T-cell acute lymphoblastic leukaemia with t(6;7) (TCRB-MYB) translocationPemantah Sandheeah Ramdeny, Khushnuma Mullanfroze, Paola de Lorenzo, et al.
Journal of Pediatric Hematology/Oncology|March 29, 2020
Clinical Utility of Radiologic Disease Reassessment in the Management of Pediatric B-Cell Non-Hodgkin LymphomaKatherine Green, Vesna Pavasovic, Sara Ghorashian, et al.
Blood Advances|October 12, 2023
Cranial radiotherapy has minimal benefit in children with central nervous system involvement in T-ALLDavid O'Connor, Melvin Joy, Amir Enshaei, et al.
British Journal of Haematology|November 29, 2011
Improved outcome of allogeneic haemopoietic stem cell transplantation for children with Philadelphia positive acute lymphoblastic leukaemiaAnshu Garg, Adhithya Sankar, Janet Williams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2025
High-Dose Methotrexate in Children and Young Adults With ALL and Lymphoblastic Lymphoma: Results of the Randomized Phase III Study UKALL 2011Amy A Kirkwood, Nicholas Goulden, John Moppett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2013
Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal amplification of chromosome 21: a comparison of the MRC ALL97/99 and UKALL2003 trialsAnthony V Moorman, Hazel Robinson, Claire Schwab, et al.
Pediatric Blood & Cancer|December 24, 2022
National advisory panels for childhood cancer in the United Kingdom: An evaluation of current practice and a best practice statement for the futureSarah Brown, Tanzina Chowdhury, Matthew Collin, et al.
Pageof 17